Structure of N-(1,3-Benzothiazol-2-yl)-N-[1-(piperidin-4-ylmethyl)-4,5-dihydro-1H-imidazol-2-yl]amine, C16H21N5S

ÖZTÜRK YILDIRIM Sema, AKKURT Mehmet, SERVI Süleyman, GENÇ Murat, SEKERCI Memet, FUN Hoong Kun

doi:10.2116/analscix.22.x171

Structure of N-(1,3-Benzothiazol-2-yl)-N-[1-(piperidin-4-ylmethyl)-4,5-dihydro-1H-imidazol-2-yl]amine, C16H21N5S

DOI Web Site 参考文献4件

ÖZTÜRK YILDIRIM Sema

Department of Physics, Faculty of Arts and Sciences, Erciyes University
AKKURT Mehmet

Department of Physics, Faculty of Arts and Sciences, Erciyes University
SERVI Süleyman

Firat University, Faculty of Science and Arts, Department of Chemistry
GENÇ Murat

Firat University, Faculty of Science and Arts, Department of Chemistry
SEKERCI Memet

Firat University, Faculty of Science and Arts, Department of Chemistry
FUN Hoong Kun

X-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia

書誌事項

公開日: 2006

DOI

10.2116/analscix.22.x171

公開者: 社団法人日本分析化学会

説明

The crystal structure of N-(1,3-benzothiazol-2-yl)-N-[1-(piperidin-4-ylmethyl)-4,5-dihydro-1H-imidazol-2-yl]amine has been determined. The compound crystallizes in monoclinic P2₁/c; a = 11.7456(2)Å, b = 10.1254(2)Å, c = 13.9107(2)Å, β = 104.669(1)°, V = 1600.46(5)Å³ and Z = 4. The final R value is 0.0483. The benzothiazol and imidazol rings are planar with the dihedral angle being 6.37(8)° between them. The piperidin ring takes a chair conformation.